The effect of exogenous nitric oxide on plasminogen activator inhibitor in experimentally induced endotoxemia

Fibrinolysis

Volumn 10, Issue 1, 1996, Pages 21-25

  Noci, M V ^a   Velasco, F ^a   Lopez, A ^a   Lopez Pedrera, R ^a   Rodriguez, M ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FIBRINOLYSIS; GLOMERULUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOSIS;

EID: 0029979260     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(05)80072-4     Document Type: Article

References (34)

1. Stuehr D J, Marletta M A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82: 7738-42.
2. 3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA 1983; 80: 4518-21.
3. Moncada S, Radomski M W, Palmer R M J. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37: 2495-501.
4. Palmer R M J, Ashton D S, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. nature 1988; 333: 664-6.
5. Marietta M A, Yoon P S, Iyengar R, Leaf C D, Wishnok J S. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706-11.
6. Palmer R M J, Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 1989; 158: 348-52.
7. Moncada S, Palmer R M J, Higgs E A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
8. Rees D D, Cellek S, Palmer R M J, Moncada S. Dexamethasone prevents the induction by endotoxin of nitric oxide synthase and the associated effects on muscular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 1990; 173: 541-7.
9. Julou-Schaeffer G, Gray G A, Fleming I, Scott C, Parratt J R, Stoclet J C. Loss of the vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1991; 259: H1038-43.
10. G-nitro-L-arginine-methyl-ester inhibits tumor necrosis factor-induced hypotension: implication for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87: 3621-32.
11. Thiemmerman C, Vane J. Inhibition of nitric oxide synthesis reduced the hypotension induced by bacterial lipopolysaccharides in vivo. Eur J Pharmacol 1990; 182: 591-4.
12. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1911; 338: 1557-8.
13. G-monomethyl-L-arginine. J Cardiovasc Pharmacol 1992; 20: S132-4.
14. Wright C E, Rees D D, Moncada S. The protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26: 48-57.
15. Hall R C, Hodge R L. Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs. J Physiol (Lond) 1971; 213: 69-84.
16. Bult H, Herman A G, Rampart M. Modification of endotoxin-induced hemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. Br J Pharmacol 1985; 84: 317-27.
17. Klabunde R E, Ritger R C. NG-monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in canine model of endotoxin shock. Biochem Biophys Res Commun 1991; 178: 1135-40.
18. Hutcheson I R, Brendan J R, Whittle B J, Boughton-Smith N K. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rate. Br J Pharmacol 1990; 101: 815-20.
19. Shultz P J, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-25.
20. Westberg G, Shultz P J, Raij L. Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats. Kidney Int 1994; 46: 711-6.
21. Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 88: 411-5.
22. Korbut R, Lidbury P S, Vane J R. Prolongation of fibrinolytic activity of tissue plasminogen activator by nitrovasodilators. Lancet 1990; 335: 881-6.
23. Lidbury P S, Korbut R, Vane J R. Sodium nitroprusside modulates the fibrinolytic system in the rabbit. Br J Pharmacol 1990; 101: 527-30.
24. Radomski M W, Palmer R M, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987; 148: 1482-9.
25. Stamler J S, Vaughan D E, Loscalzo J. Synergistic disaggregation of platelets by tissue-type plasminogen activator, prostaglandin El and nitroglycerin. CircRes 1989; 65: 796-804.
26. Drummer C, Ludke S, Spannagl M, Schramm W, Ferzer R. The nitric oxide donor SIN-I is a potent inhibitor of plasminogen activator inhibitor release from stimulated platelets. Thromb Res 1991; 63: 553-6.
27. Kruithof E K O, Tran-Thang C, Ransijin A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-13.
28. Colucci M, Paramo J A, Collen D. Generation in plasma of a fast-acting inhibitor in response to endotoxin stimulation. J Clin Invest 1985; 75: 818-24.
29. Korbut R, Warner T D, Gryglewski R J, Vane J R. The effect of nitric oxide synthase inhibition on the plasma fibrinolytic system in septic shock in rats. Br J Pharmacol 1994; 112: 289-91.
30. Teger-Nilsson A C, Friberger P, Gyzander E. Determination of a new rapid plasma inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest 1977; 37: 403-4.
31. Mussoni L, Raczka E, Chmielewska J, Donati M B, Latallo Z S. Plasminogen assay in rabbit, rat and mouse plasma using the chromogenic substrate S-2251. Thromb Res 1979; 15: 341-9.
32. Billiar T R, Curran R D, Harbrecht B G, Stuehr D J, Demetris A J, Simrnons R L. Modulation of nitric oxide synthesis in vivo: NG-Monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukocyte Biol 1990; 48: 565-9.
33. Kruithof E K O, Tran-Thang C, Bachmann F. Studies on the release of a plasminogen activator inhibitor by human platelets. Thromb Haemostas 1986; 55: 201-5.
34. Erickson L A, Ginsberg M H, Loskutoff D J. Detection and characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984; 74: 1465-72.